Lacosamide for treatment-resistant bipolar disorder: a open-label study (Lacosamide for bipolar disorder)

未提供0 个研究点目标入组 20 人开始时间: 2018年4月16日最近更新: 2020年9月23日

适应症

试验速览

暂无简介。

•The clinical trial was described in detail to the subjects, and written informed consent was obtained from all participants and their guardians.
•patients age: 20 > years olds and < 70 years old
•Patients met at least 2 the following inclusion criteria -Patients did not improve their symptoms using at least one mood stabilizer with adequate dose for 4 weeks or more than 4 weeks.
•Patients did not improve their symptoms using at least one second generation antipsychotic with adequate dose for 4 weeks or more than 4 weeks.
•Patients did not improve their symptoms using combination therapy of mood stabilizer with second generation antipsychotic with adequate dose for 4 weeks or more than 4 weeks.

•patients receiving electroconvulsive therapy within 6 months prior to the study enrollment.
•no pregnancy, no lactation.
•no severe physical illness.
•no neurological disease.
•patients have suicidal ideation.
•patients judged that researchers are inappropriate to participate in the study

Clinical Global Impression-Severity

未报告次要终点

发起方

未提供